David E. Kelley

Merck & Co., Inc., Rahway, NJ, USA (United States) — United States

Medicine · Health Sciences

91h-index39.3kcitations264works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Adipose Tissue and Metabolism(83), Diet and metabolism studies(66), Muscle metabolism and nutrition(64), Metabolism, Diabetes, and Cancer(39), Diabetes Treatment and Management(25)

Publications262 total

Effects of weight loss on testosterone, sex hormone‐binding globulin, adiposity, and insulin sensitivity in women and men
Obesity·2025· 1 cited
706 Empanelment is necessary but not sufficient for continuity of patient care
The American Journal of the Medical Sciences·2025
314-OR: A Randomized Study of a GPR119 Agonist on Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes Mellitus (T1DM)
Diabetes·2024
Author Correction: Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists
Nature Communications·2024· 1 citedOpen Access
Low SWaP, commercially-available Geiger-mode lidar system
2022· 4 cited
Discovery of Insulin Receptor Partial Agonists MK-5160 and MK-1092 as Novel Basal Insulins with Potential to Improve Therapeutic Index
Journal of Medicinal Chemistry·2022· 10 cited
Rare Earth Image Bank: Extraction Geology and Stock Photos, from Wyoming to Inner Mongolia
2022
Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists
Nature Communications·2022· 27 citedOpen Access
A Practitioner's Guide and <i>MATLAB</i> Toolbox for Mixed Frequency State Space Models
Journal of Statistical Software·2022· 4 citedOpen Access
Muscle insulin resistance in type 1 diabetes with coronary artery disease
Diabetologia·2020· 3 citedOpen Access
A Practitioner's Guide and MATLAB Toolbox for Mixed Frequency State Space Models
SSRN Electronic Journal·2020· 5 citedOpen Access
PAN-AMPK Activation Improves Renal Function in a Rat Model of Progressive Diabetic Nephropathy
Journal of Pharmacology and Experimental Therapeutics·2019· 25 citedOpen Access
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
Science·2019· 433 citedOpen Access
Spatial and temporal studies of metabolic activity: contrasting biochemical kinetics in tissues and pathways during fasted and fed states
American Journal of Physiology-Endocrinology and Metabolism·2019· 10 citedOpen Access
Pharmacological AMPK activation induces transcriptional responses congruent to exercise in skeletal and cardiac muscle, adipose tissues and liver
PLoS ONE·2019· 41 citedOpen Access
A new “big data” index of U.S. economic activity
Economic Perspectives·2019· 40 citedOpen Access
A “big data” view of the U.S. economy: Introducing the Brave-Butters-Kelley Indexes
Chicago Fed Letter·2019· 2 citedOpen Access
Which leading indicators have done better at signaling past recessions?
Chicago Fed Letter·2019· 4 citedOpen Access
External parasitic twins
Journal of Pediatric Surgery Case Reports·2018· 1 citedOpen Access
Clinical Evaluation of <scp>MK</scp>‐2640: An Insulin Analog With Glucose‐Responsive Properties
Clinical Pharmacology & Therapeutics·2018· 39 cited
page 1 of 14Next →

Frequent Co-authors

Bret H. Goodpaster(18), F. Leland Thaete(7), Jing He(5), Vladimir B. Ritov(5), Jean‐Aimé Simoneau(5), Samuel Klein(4), Elizabeth V. Menshikova(3), James O. Hill(3), Thomas A. Wadden(3), Rena R. Wing(3), Anne B. Newman(3), Lewis H. Kuller(3), Simon C. Watkins(3), Frederico G. S. Toledo(3), David B. Allison(3), Steven B. Heymsfield(3), Rudolph L. Leibel(3), Cathy Nonas(3), Richard Kahn(3), J. A. Simoneau(3)